A comparative study on the value of lower airway exhaled nitric oxide combined with small airway parameters for diagnosing cough-variant asthma
Open Access
- 1 January 2023
- journal article
- research article
- Published by SAGE Publications in Therapeutic Advances in Respiratory Disease
- Vol. 17
Abstract
Background: The diagnosis of cough-variant asthma (CVA) is based on bronchial provocation test, which is challenging to be conducted. Most CVA patients have type 2 airway inflammation and small airway dysfunction. FeNO200, reflecting small airway inflammation, may be used to diagnose CVA. Objective: This study aimed to explore and compare the value of lower airway exhaled nitric oxide (FeNO50, FeNO200, and CaNO) combined with small airway parameters for diagnosing CVA. Methods: Chronic cough patients who attended the clinic from September 2021 to August 2022 were enrolled and divided into CVA group ( n = 71) and non-CVA (NCVA) group ( n = 212). The diagnostic values of FeNO50, FeNO200, concentration of alveolar nitric oxide (CaNO), maximal mid-expiratory flow (MMEF), forced expiratory flow at 75% of forced vital capacity (FEF75%) and forced expiratory flow at 50% of forced vital capacity (FEF50%) for CVA were evaluated. Results: FeNO50 [39(39) ppb versus 17(12) parts per billion (ppb), p < 0.01], FeNO200 [17(14) ppb versus 8(5) ppb, p < 0.01] and CaNO [5.0(6.1) ppb versus 3.5(3.6) ppb, p < 0.01] in CVA group were significantly higher than those in NCVA group. The optimal cut-off values of FeNO50, FeNO200, and CaNO for diagnosis of CVA were 27.00 ppb [area under the curve (AUC) 0.88, sensitivity 78.87%, specificity 79.25%], 11.00 ppb (AUC 0.92, sensitivity 88.73%, specificity 81.60%) and 3.60 ppb (AUC 0.66, sensitivity 73.24%, specificity 52.36%), respectively. For diagnosing CVA, the value of FeNO200 was better than FeNO50 ( p = 0.04). The optimal cut-off values of MMEF, FEF75%, and FEF50% for the diagnosis of CVA were 63.80% (AUC 0.75, sensitivity 53.52%, specificity 86.32%), 77.9% (AUC 0.74, sensitivity 57.75%, specificity 83.49%) and 73.50% (AUC 0.75, sensitivity 60.56%, specificity 80.19%), respectively. The AUCs of FeNO50 combined with MMEF, FEF75%, and FEF50% for the diagnosis of CVA were all 0.89. The AUCs of FeNO200 combined with MMEF, FEF75%, and FEF50% for the diagnosis of CVA were all 0.93. Conclusion: FeNO200 > 11 ppb contributed strongly for differentiating CVA from chronic cough, especially in patients with small airway dysfunction.Keywords
Funding Information
- National Natural Science Foundation of China (82070102)
- National Natural Science Foundation of China (82270114)
This publication has 22 references indexed in Scilit:
- Validity of fractional exhaled nitric oxide and small airway function indices in diagnosis of cough-variant asthmaJournal of Asthma, 2017
- A European Respiratory Society technical standard: exhaled biomarkers in lung diseaseEuropean Respiratory Journal, 2017
- Could Fractional Exhaled Nitric Oxide Test be Useful in Predicting Inhaled Corticosteroid Responsiveness in Chronic Cough? A Systematic ReviewThe Journal of Allergy and Clinical Immunology: In Practice, 2017
- A Novel Approach to Partition Central and Peripheral Airway Nitric OxideChest, 2014
- Leukotriene receptor antagonists for small-airway abnormalities in asthmatics: a systematic review and meta-analysisJournal of Asthma, 2013
- A Prospective, Multicenter Survey on Causes of Chronic Cough in ChinaChest, 2013
- Small-airways dysfunction associates with respiratory symptoms and clinical features of asthma: A systematic reviewJournal of Allergy and Clinical Immunology, 2013
- Pathogenesis of Small Airways in AsthmaRespiration, 2012
- PFT Interpretive Strategies: American Thoracic Society/ European Respiratory Society 2005 Guideline GapsRespiratory Care, 2012
- ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005American Journal of Respiratory and Critical Care Medicine, 2005